Research

Articles and Abstracts Published by UConn Nephrology Fellows

Hassan Bin Attique

Graduated 2018

  1. Attique HB, Trivedi R, Successful treatment of Hashimoto encephalopathy with therapeutic plasma exchange, Ther Apher Dial. 2020; 1-2, PMID: 31863616 DOI: 10.1111/1744-9987.13466
  2. Attique, Hassan B, Mazigh, Silya, Trivedi, R. Renal Salt Wasting (RSW) with Normonatremia Secondary to Acquired Mineralocorticoid Deficiency, PUB 748, ASN, San Diego, Oct 23-28, 2018.
  3. Attique HB, Trivedi R, Naik S, Haroon A, Singh C. Klebsiella pneumoniae Peritonitis could be a Potential Risk Factor for Portal Vein Thrombosis in Patients on Peritoneal Dialysis- a Case Report. Int J Nephrol Ther. 2017;3(1): 035-039
  4. Gomez LK, Little E, Attique H, Trivedi R (2017) A Bubbly Nephron-Emphysematous Pyelonephritis, A case report and Literature Review. JSM Renal Medicine 2 (1):1011 (2017)
  5. Attique H, Naik S, Haroon A, Trivedi R Long Term Peritoneal Dialysis May Result in Vascular Changes within the Peritoneal Cavity Leading to Reduced Efficacy of Intravenous Antibiotics in Treatment of Bacterial Peritonitis. Am J Med. Volume 130, Issue 10, October 2017, Pages e449-e450, doi: 10.1016/j.amjmed.2017.05.015? Epub 2017 Jun 7, PMID: 28601541
  6. Attique H, Trivedi R etal, Successful Treatment of Hashimoto Encephalopathy with Therapeutic Plasma Exchange University of CT Health Center, West Hartford, CT. J Am Soc Nephrol 28: 2017 FRPO:044

Ibrahim El-Ali

Graduated June 2016

  1. Ibrahim M. El-Ali, Chandana Shekar, Sarthak Virmani, Ruchir D. Trivedi. Propofol Induced Hyperkalemia in a Hemodialysis Patient, presented at the annual ASN meeting, JASN 2015; 26:360A
  2. Ibrahim M. El-Ali, Ana Claudia Onuchic, Ruchir D. Trivedi, Improvement of Renal Function with Treatment of Hypothyroidism, presented at the annual ASN meeting, JASN 2015; 26:630A
  3. Ibrahim M. El-Ali, Chandana Shekar, Sarthak Virmani, Ruchir D. Trivedi. Propofol Induced Hyperkalemia in a Hemodialysis Patient, presented at the annual ASN meeting, JASN 2015; 26:360A
  4. Ibrahim M. El-Ali, Ana Claudia Onuchic, Ruchir D. Trivedi, Improvement of Renal Function with Treatment of Hypothyroidism, presented at the annual ASN meeting, JASN 2015; 26:630A

Sajan Eapen

July 1, 2012 to June 30, 2014

  1. Using fresh frozen plasma with therapeutic plasma exchange in a patient with acquired C1 esterase inhibitor deficiency without triggering angioedema, Sajan Eapen, M.D., UConn Health, American Society of Nephrology, November 8, 2013.
  2. Refractory hypokalemia with sustained ventricular tachycardia as the presenting sign of metastatic cancer, Sajan Eapen, M.D., UConn Health, American Society of Nephrology, November 7, 2013.

Gaurav Alreja

July 1, 2013 to June 30, 2015

  1. Adalimumab induced antibody formation causing class V lupus nephritism, Gaurav Alreja, M.B.B.S., UConn Health, National Kidney Foundation, April 22, 2014.

Dhruva Chawla

July 1, 2011 to June 30, 2013

  1. ANCA associated cresentic glomerulonephritis presenting as pulmonary renal syndrome in a sewage worker: possible link to aromatic hydrocarbon genotoxicity, Ruchir Trivedi, Dhruva Chawla, Wilner Samson, Harold Yamase, Joseph Palmisano, Andre Kaplan, UConn Health, National Kidney Foundation, 2012.

Ruchir D. Trivedi

July 1, 2010 to June 30, 2012

  1. Prolonged symptomatic hypocalcemia from Hungry Bone Syndrome after parathyroidectomy Ruchir Trivedi MD, Nancy Day Adams MD and Andre A Kaplan MD University of Connecticut Health Center, Farmington, CT 06032, National Kidney foundation, 2011.
  2. Oral supplementation of 15 grams of amino acids administered thrice weekly increases serum albumin levels in maintenance hemodialysis patients. Ruchir Trivedi MD, Meredith Marinaro MS, RD and Andre A Kaplan MD, UConn Dialysis Center, Dialysis Clinics Inc., and University of Connecticut Health Center, Farmington, CT 06032, National Kidney Foundation Meeting, 2011.
  3. Safety of Regional Heparinization for ultrafiltration using heparin and protamine Ruchir Trivedi MD, and Andre A. Kaplan MD, University of Connecticut Health Center, Farmington, CT 06032. National Kidney Foundation Meeting, 2011.
  4. De Novo Presentation of Normo-reninemic Scleroderma Renal Crisis (SRC) in a patient with undifferentiated vasculitis. Ruchir Trivedi MD, Wilner Samson MD, Nancy Day Adams MD, and Harold Yamase MD. University of Connecticut Health Center, Farmington, CT 06032. National Kidney Foundation Meeting, 2011.
  5. Hyponatremia secondary to cervical spine trauma, ACP Annual Conference, Connecticut, 2007, poster presentation.
  6. Esomeprazole induced acute interstitial nephritis causing Acute Renal Failure, a rare complication, ACP Annual Conference, 2007, poster presentation.
  7. Renal Tubular Acidosis- when obvious is not so obvious, ACP, Annual Conference 2007 poster/oral presentation.
  8. Ruchir Trivedi, Gautam Das, Joanne Cutler & Parijat De, A case of recurrent hypoglycemia in a patient with type 1 diabetes: when the obvious is not so obvious! Endocrine Abstract BES 2007 :13, P38.
  9. Trivedi. R, Bello. AK, Morris. B, 1 El Nahas AM Prevalence of Undetected CKD (Stages 3-5) among Diabetics and CVD patients in a Large Tertiary Health Centre. Sheffield Kidney Institute, Northern General Hospital, Sheffield Teaching Hospital NHS Trust, Sheffield. Renal Association UK, 2005, RA5164.
  10. Adverse Reactions to HAART in a teaching hospital – International HIV workshop on treatment experienced patients, San Diego, U.S.A. Sep 2002, (Publication March 2003).
  11. Trivedi R, SM Patel et al, “Placental Cord blood transplantation- Present & Future Considerations” Indian Journal of Medical & Paediatric Oncology, Nov 2002:13, 18-23.
  12. Trivedi R,Patel RK “Worsening of CNS Tuberculosis after initiation of Antituberculous therapy”, Gujarat Medical journal, April 2000:57;85-87.
  13. Trivedi R et al “Leukotriene Receptor Antagonists in Bronchial Asthma”, Gujarat Medical journal : July 2000:58; 15-19.
  14. Amin B, Trivedi R “Glucose-6-phosphate dehydrogenase deficiency and unstable haemoglobin disease presenting as Haemolytic Anaemia” Gujarat Medical Journal:July 2000:58;23-24.
  15. Trivedi R et al, “Pure Red Cell Aplasia associated with Thymoma”, Gujarat Medical Journal: March 2001, Vol 58, 73-75.
  16. Trivedi R, Dharajia N, et al, “Gene Therapy – Where do we stand?” Gujarat Medical Journal: Nov.2000, Vol 59, 5-9.

Erik M. Wendland

July 1, 2009 to June 30, 2011

  1. Erik Wendland, Andre A. Kaplan: Proposed dialysis prescription for anuric patients with severe hyponatremia.
    Seminars in Dialysis. Article first published online: 9 SEP 2011. DOI: 10.1111/j.1525139X. 2011.00981.x © 2011
    Wiley Periodicals, Inc.
  2. Wendland E, Kaplan A: Proposed dialysis prescription for anuric patients with severe hyponatremia. Abstract
    submited to the National Kidney Foundation for clinical meetings in April 2011, approved for poster.
  3. Wendland E, Palmisano J, Dunn M, Yamase H, Adams N: Hippuric acid not calcium oxlate crystals in the urine of
    a patient with ethylene glycol ingestion. Abstracted submitted to the National Kidney Foundation for clinical
    meetings in April 2011, poster presentation.
  4. Wendland E, Palmisano, Dunn M, Samson W, Adams N: A case of iatrogenic spontaneous bladder rupture
    following renal biopsy. Abstract submitted to the National Kidney Foundation for clinical meetings in April 2011,
    poster presentation.

Beje Thomas

July 1, 2008 to June 30, 2010

  1. Thomas, B., Zar, T., Allen, S., Plasmapheresis in neuromyeltis optica (NMO). NKF 2007 Spring Clinical Meeting, Abstract 222, 2007.
  2. Nataraj S, Vellanki V, Thomas B, D'Avella J, Ranga V: Utility of renal isotope scan in predicting delayed graft
    function. Poster at American Society of Nephrology Meeting, October 2009.
  3. Thomas B, Dunn A: Salicylate poisoning and dialysis. Poster at National Kidney Foundation Scientific Meeting,
    April 2009.
  4. Aglieco F, Thomas B, Samson W, Kaplan A: Safe and effective administration of Epoetin alfa in anemia of sickle
    cell disease and kidney failure. Poster at National Kidney Foundation Scientific Meeting, April 2009.
  5. Purvi S, Gupta S, Thomas B, Kaplan A: Leukapheresis for hyperleukocytosis. Poster at National Kidney
    Foundation Scientific Meeting, April 2010.

Fabio Aglieco

July 1, 2007 to June 30, 2009

  1. D’Mello, S.R., Aglieco F., M.R. Roberts, K. Borodezt, J.W. Haycock. A DEVD-inhibited caspase other than CPP32 is involved in the commitment of cerebellar granule neurons to apoptosis induced by K+ deprivation. Journal of Neurochemistry, 70:1809-1818, 1998.
  2. Fjell, J., P. Hjelmstrom, W. Hormuuzdiar, M. Milenkovic, F. Aglieco, L. Tyrrell, S.D. Dib-Hajj, S.G. Waxman and J.A. Black. Localization of the tetrodotoxin-resistant sodium channel NaN in nociceptors. NeuroReport, 11:199-202, 2000.
  3. Cummins, T.R., Aglieco, F., M. Renganathan, R.I. Herzog, S.D. Dib-Hajj and S.G. Waxman. Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. Journal of Neuroscience, 21:5952-5961, 2001.
  4. Cummins, T.R., Aglieco, F. and S.D. Dib-Hajj. Critical Molecular Determinants of Voltage-Gated Sodium Channel Sensitivity to mu-Conotoxins GIIIA/B. Molecular Pharmacology, 61:1192-1201, 2002.
  5. Aglieco F, Manickaratnam S, Bona R, Kaplan AA., A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab. Ther Apher Dial. 12:185-9, 2008.
  6. Zar T, Aglieco F, Ranga KV., Quiz page April 2008: deafness, preauricular pits, and renal failure. BOR syndrome or Melnick-Fraser syndrome. Am J Kidney Dis. 51:A44-6, 2008.
  7. Datla A, Aglieco F, Dada AM, Samson W., Minimal Change Disease (MCD) Presenting as Acute Kidney Injury and Nephrotic-Range Proteinuria Without Edema, Amer J Kid Dis., #55, 51:B41, 2008.
  8. Aglieco F, Bansal, R, Kaplan AK., Expanded Plasma Volume in Waldenstrom’s Macroglobulinemia as Evidenced by IGM Reduction Ratios During Therapeutic Plasma Exchange (TPE), Amer J Kid Dis., #3, 51:B28, 2008.
  9. Aglieco F, Thomas B, Samson W, Kaplan A. Safe and effective administration of Epoetin alfa in anemia of sickle
    cell disease and kidney failure. National Kidney Foundation Spring Clinical Meeting, April 2009, poster presentation.

M. Atiq Dada

July 1, 2006 to June 30, 2008

  1. Dada M.A., Kaplan A.A., Plasmapheresis treatment in Guillain-Barre syndrome: potential benefit over IVIg in patients with axonal involvement. Ther Apher Dial. 8:409-12, 2004.
  2. Dada MA, Srinagesh P, Whitaker C and Kaplan A. Response to Plasmapheresis Treatment in Myasthenia Gravis Patients Who Fail IVIg (Intravenous Immunoglobulin). Journal of the American Society of Nephrology 18: 251A, 2007.
  3. Zar T., Dada, A.M., Kaplan, A.A., Predictable Removal of Anticardiolipin Antibody (aCL AB) by Therapeutic Plasma Exchange (TPE) in a Patient with Catastrophic Antiphospholipid Antibody Syndrome (CAPS) Amer J Kid Dis #244, 49:B85, 2007.
  4. Sathyan S., Nataraj S., Dada M.A., Ranga K.V., Clinical Improvement in Nephrogenic Systemic Fibrosis (NSF) Following Renal Transplantation: Should ‘NSF Points’ be Considered in Allocation? Amer J Kid Dis, #233, 51:B86, 2008.
  5. Nataraj S., Vellanki V., Dada, M.A., Balarezo F., Ranga, K.V., De Novo Focal Segmental Glomerulosclerosis (FSGS) Following Renal Transplant In A Patient With Autosomal Dominant Polycystic Kidney Disease (ADPKD) Amer J Kid Dis, #181, 51:B73, 2008.
  6. Krishnaswamy, J., Dada, M.A., Adams , N.D., No Improvement in Creatinine Despite Dialysis When Poisoned, Amer J Kid Dis, #127, 51:B59, 2008.
  7. Datla A, Aglieco F, Dada MA, Samson W., Minimal Change Disease (MCD) Presenting as Acute Kidney Injury and Nephrotic-Range Proteinuria Without Edema, Amer J Kid Dis., #55, 51:B41, 2008.

Tausif M. Zar

July 1, 2005 to June 30, 2007

  1. Zar T, Samson W, and Palmisano J., Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with systemic lupus erythematosus (SLE) and lupus nephritis. Nephrol Dial Transplant. 22:2400-1, 2007.
  2. Zar T, Graeber C, Perazella MA., Recognition, treatment, and prevention of propylene glycol toxicity. Semin Dial. 20:217-9, 2007.
  3. Zar T, Zar R, and Kaplan AA., Candidemia-induced acute interstitial nephritis. Nephrology (Carlton). 12:528-9, 2007.
  4. Zar T, Yusufzai I, Sullivan A, and Graeber C. Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam. Nat Clin Pract Nephrol. 3:515-20, 2007.
  5. Zar, T., See, S.Y., and Ranga, K.V. Early and aggressive recurrence of idiopathic membranous nephropathy in a renal transplant recipient. NKF 2007 Spring Clinical Meeting, Abstract 243, A85, 2007.
  6. Zar, T., Dada, A.T., and Kaplan, A.A. Predictable removal of anticardiolipin antibody (aCL AB) by therapeutic plasma exchange (TPE) in a patient with catastrophic antiphospholipid antibody syndrome (CAPS). NKF 2007 Spring Clinical Meeting, Abstract 24, A85, 2007.
  7. Thomas, B., Zar, T., Allen, S., Plasmapheresis in neuromyeltis optica (NMO). NKF 2007 Spring Clinical Meeting, Abstract 222, 2007.
  8. Zar T, Gyebi L, Kaplan AA, Adams ND. Impact of maintenance intravenous iron protocol on management of anemia in dialysis patients. International society for Peritoneal Dialysis, North American Chapter annual meeting, Miami, Fl, June 2007.
  9. Zar T, Aglieco F, Ranga KV., Quiz page April 2008: deafness, preauricular pits, and renal failure. BOR syndrome or Melnick-Fraser syndrome. Am J Kidney Dis. 51:A44-6, 2008.
  10. Zar T, Peixoto AJ., Paroxysmal hypertension due to baroreflex failure. Kidney Int. 74:126-31, 2008.
  11. Zar T, Zar R, Kaplan AA., Candidemia-induced acute interstitial nephritis. Nephrology (Carlton). 12:528-9, 2007.
  12. Zar T, Kaplan AA: Predictable removal of anticardiolipin antibody by therapeutic plasma exchange in a patient with catastrophic antiphospholip antibody syndrome (CAPS). Clin Nephrol 70:77-81, 2008.

Niranjan Sankaranarayanan

July 1, 2001 to June 30, 2004

  1. Sankaranarayanan N., Kaplan, A.A., and Palmisano, J. Dramatic reversal of acute renal failure (ARF) with therapeutic plasma exchange (TPE) in a case of multiple myeloma. 21st Annual Meeting of the International Society of Blood Purification (ISBP), Blood Pruif A22, 21:350-367, 2003.
  2. Sankaranarayanan N., Kaplan, A.A., and Palmisano, J. IgA myeloma related ARF-rapid reversal with therapeutic plasma exchange (TPE). 2003 Spring Clinical Meeting, Abstract 84, A32, 2003.
  3. Sankaranarayanan N., Kaplan, A.A., Palmisano, J., Yamase, H., Sanders, M., Strongwater, S., and Adams, N.A. Fulminant IgA anti-GBM disease in a patient with two rare autoimmune disorders. NKF 2004 Spring Clinical Meeting, Abstract 103, A40, 2004.
  4. Sankaranarayanan N., Palmisano, J., Kaplan, A.A., Adams, N.A., and Yamase, H. Vasulopathy in SLE nephritis – an entity neglected. NKF 2004 Spring Clinical Meeting, Abstract 104, A40, 2004.
  5. Sankaranarayanan N., Agrawal R., Guinipero L., Kaplan A.A., and Adams N.D. Self-performed peritoneal dialysis in prisoners. Adv Perit Dial. 20:98-100, 2004.
  6. Sankaranarayanan N, Santos SF, and Peixoto AJ. Blood pressure measurement in dialysis patients. Adv Chronic Kidney Dis., 11:134-42, 2004.